FRANKLIN LAKES, N.J., Sept. 26, 2024 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new data that highlights how its advanced artificial intelligence technology can help health systems better identify incidents of controlled substance diversion in the operating room.
Hospital drug diversion occurs when a health care worker “diverts” opioids or other controlled substances away from patients for personal use or […]
New Data Reveals BD's Artificial Intelligence Software Highly Effective in Detecting …